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The mammalian target of rapamycin (mTOR) kinase is a critical regulator of mRNA
translation and is suspected to be involved in various long-lasting forms of synaptic and
behavioral plasticity. However, its role in motor learning and control has never been
examined. This study investigated, in mice, the implication of mTOR in the learning
processes associated with the accelerating rotarod task.We ﬁrst observed that the rotarod
learning did not alter the levels of total mTOR in the striatum, hippocampus, cerebellum,
and anterior cortex of trained mice. However, it increased the levels of phosphorylated
mTOR in the striatum and hippocampus exclusively during the ﬁrst session of training; no
change was observed at the second and third sessions. In order to further investigate
the potential role of mTOR during motor skill learning, we performed systemic and
intrastriatal inhibitions of mTOR using the pharmacological inhibitor rapamycin, as well as
a genetic knockdown of striatal mTOR using intrastriatal infusion of mTOR siRNA. These
three independent approaches were all associated with a signiﬁcant reduction in rotarod
performances that were reminiscent of impaired consolidation processes. Notably, these
treatments did not affect the capacity of mice to execute the pole test, suggesting that
mTOR activity was mainly controlling motor learning rather than motor abilities. Moreover,
all treatments decreased the levels of phosphorylated 4EBP1 and P70S6K, two molecular
downstream targets of mTORC1. Our ﬁndings demonstrate that striatal mTOR kinase,
via the phosphorylation of 4EBP1 and P70S6K, plays an important role in the cellular and
molecular processes involved in motor skill learning.
Keywords: 4EBP1, motor learning, mTOR, P70S6K, rapamycin, rotarod, siRNA
INTRODUCTION
When faced to new learning experiences, one fascinating charac-
teristic of the brain is its capacity to modulate neural activities and
induced long-lasting modiﬁcations in neural circuits. These mod-
iﬁcations subsequently inﬂuence thoughts, feelings and behaviors
(Citri and Malenka, 2008). In the case of motor control and learn-
ing, it is known that brain areas such as the basal ganglia, motor
cortex, and cerebellum cooperate to enable movement (Lynch,
2004). Recent investigations have shown regional-speciﬁc changes
in neural activity andmorphology during the acquisition of motor
tasks in the striatum, a major nucleus input of the basal gan-
glia (Packard and Knowlton, 2002; Kreitzer and Malenka, 2008).
For example, it is believed that the dorsal area of the striatum
plays a signiﬁcant role in the learning processes of motor skilled
tasks (Costa et al., 2004; Luft et al., 2004). However, the molecu-
lar mechanism responsible for the long-lasting modiﬁcations in
the dorsal striatum during motor learning is still under extensive
investigations.
Interestingly, the mammalian target of rapamycin (mTOR)
activity has been noticed to be essential in neuronal development,
translation of severalmRNAs and synaptic plasticity (Bekinschtein
et al., 2007; Swiech et al., 2008; Belelovsky et al., 2009; Richter and
Klann, 2009). This serine/threonine kinase forms two complexes,
mTORC1 and mTORC2. The ﬁrst complex plays a major role
in regulating critical cellular processes such as cell growth, pro-
liferation, transcription, protein synthesis as well as ribosomal
biogenesis by phosphorylating P70S6K and eukaryotic initiation
factor 4E (eIF4E)-binding proteins (4EBPs; Sarbassov et al., 2005;
Wang and Proud, 2006; Hoeffer and Klann, 2009; Urbanska et al.,
2012). The second complex is involved in cytoskeletal organization
(Jacinto et al., 2004; Sarbassov et al., 2006). Recently, it has been
demonstrated that molecular pathways involving mTOR activity
are essential for the long-term potentiation (LTP) and long-term
depression (LTD; Gkogkas et al., 2010; Garelick and Kennedy,
2011). Furthermore, behavioral experiments investigating spatial
learning, object recognition and inhibitory avoidance memory
have recognized a role for mTOR activity (Qi et al., 2010; Jobim
et al., 2011a,b). Whether mTOR activity is inﬂuenced or engaged
during the execution of motor movement and motor learning is
totally unknown.
The present study establishes, by using two different pharma-
cological and one genetic approaches, that mTOR activity of the
dorsal striatum is one important molecular step involved in learn-
ing consolidation, but not motor abilities, during the acquisition
of a complex motor skill in mice. Notably, we demonstrate the
implication of two downstream targets of mTORC1 activation,
P70S6K and 4EBP1, in this process.
MATERIALS AND METHODS
ANIMALS
C57bl/6j male mice of 60–75 days old (Charles River, St-Constant,
QC, Canada) were used. They were individually housed in a con-
trolled room (light cycle: 14 h; dark cycle: 10 h) with ad libitum
access to water and food. All experiments and procedures were
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approved by the UQTR Institutional Animal Care and Use Com-
mittee and performed in accordance with the Canadian Council
on Animal Care.
ROTAROD
To assess motor skill learning, we used the accelerating rotarod.
Mice performances on the rotarod (AccuScan Instruments,
Columbus, OH, USA), which accelerates from 4 to 40 rpm in
300 s, were evaluated for 10 trials per session on three consecutive
days. A resting time of 180 s was allowed between each trial. The
end of a trial was considered when mice were falling off the rod
or when they reached 300 s. Latency to fall was recorded for each
trial.
POLE TEST
The pole test was performed before the ﬁrst trial of the third
rotarod training day, 15 min after the systemic or intrastriatal
rapamycin injections or at the 14th day of siRNA infusion. Brieﬂy,
the pole test consist of a vertical rod (Diameter: 1.5 cm; Length:
50 cm) ﬁxed on a table with a tennis ball at its upper end. Mice
were placed on the upper end of the rod facing the tennis ball.
The time required for each mouse to turn around and descend the
vertical rod was recorded. A maximum time of 120 s was allowed
to execute the task. To make sure they fully learned the motor task
before the recorded test, mice were pre-trained three consecutive
times.
PHARMACOLOGICAL TREATMENTS
For systemic treatment, mice were weighed and systemically
injected with vehicle (100% DMSO, 180–210 μl) or rapamycin
(40 mg/kg, dissolved in 100% DMSO, 180–210 μl; LC laborato-
ries, Woburn, MA, USA) 15 min prior each rotarod training days
(Figure 1A). In order to discriminate motor endurance activity
from motor skill learning, an independent cohort of mice were
trained on the accelerating rotarod for four consecutive days. At
the fourth day, mice received systemic injections of rapamycin or
the vehicle before the beginning of the ﬁrst trial. For intrastri-
atal treatment, mice were anesthetized under isoﬂurane, placed
in a stereotaxic apparatus and implanted with a bilateral 26-gage
guide cannula (Plastics One, Roanoke, VA, USA). The coordi-
nates used for the cannula implantation were: AP: + 0.86 mm;
ML ± 1.50 mm; DV: −3.25 mm relative to Bregma (Atlas of
Paxinos and Franklin, 2001). After the surgery, 7 days of recov-
ery were given to the mice before starting the experiments. A
dummy cannula (Plastics One, Roanoke, VA, USA) was left in
place throughout the experiment. Under anesthesia, 15 min prior
the ﬁrst trial of each rotarod training days, the dummy cannula
was replaced by the injector. Injection of vehicle (100% DMSO,
1μl/side) or rapamycin (1 ng/1μl/side, dissolved in 100% DMSO;
LC laboratories, Woburn, MA, USA) was delivered into the dor-
sal striatum of both hemispheres at a constant ﬂow of 0.5 μl/min
by the micro injector pump (Harvard Apparatus, Montréal, QC,
Canada; Figure 1B).
siRNA KNOCKDOWN
Mice were anesthetized under isoﬂurane and positioned in a
stereotaxic frame. A bilateral connector cannula (Plastics One)
FIGURE 1 | Illustration depicting the experimental design. All animals
were subjected to the same handling treatment before the experiments.
(A) For systemic treatment, mice were injected systemically with vehicle
(DMSO) or rapamycin 15 min prior each rotarod training session. (B) For
intrastriatal treatment, a bilateral guide cannula was implanted in the dorsal
striatum of mice. After the surgery, seven days of recovery were given to
the mice before starting the experiments. 15 min prior the ﬁrst trial of each
rotarod training days, injection of vehicle (DMSO) or rapamycin was
delivered into the dorsal striatum of both hemispheres. (C) For intrastriatal
siRNA infusion, a bilateral connector cannula was installed into the dorsal
striatum. Two osmotic mini-pumps were surgically placed subcutaneously
on each side of the scapulae and connected to the cannula via a plastic
connector. Mice were receiving for 14 consecutive days a continuous
intrastriatal infusion with either distillated/deionized water DNase/RNase
free or mTOR siRNA. Mice were trained on the rotarod on the 12th, 13th,
and 14th days of treatment.
was installed into the dorsal striatum at the following coordinates:
AP: + 0.86 mm; ML: ± 1.50 mm; DV: −3.25 mm relative to
Bregma (Atlas of Paxinos and Franklin, 2001). It was kept in place
with Loctite instant adhesive. Two osmotic mini-pumps (Alzet,
Cupertino, CA, USA, Model 1002) were surgically placed sub-
cutaneously on each side of the scapulae and connected to the
cannula via a plastic connector. Osmotic pumps were preﬁlled
with either distillated/deionized water DNase/RNase free (EMD
Millipore, 6 μl/day) or mTOR siRNA (1.44 nmol/day, diluted
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in 100% ddH2O DNase/RNase free, Sigma-Aldrich, Oakville,
ON, Canada) and mice were receiving a continuous intrastri-
atal infusion for 14 consecutive days. Mice were trained on
the rotarod on the 12th, 13th, and 14th days of treatment
(Figure 1C).
WESTERN BLOT ANALYSIS
In all cases, mice were sacriﬁced 15 min after the last trial
of their last rotarod training day and brains were immedi-
ately removed. The striatum, hippocampus, cerebellum, and
anterior cortex were dissected, frozen on dried ice and pre-
served at −80◦C. Protein extractions of each structure were
made by homogenizing the tissue in a solution of RIPA buffer
containing 65 mM Tris base, 0.15 M NaCl, 0.1% Triton-100x,
0.25% SDS, 1 mM EDTA and protease/phosphatase inhibitors
cocktail (Roche, Indianapolis, IN, USA). The Bradford assay
(Bio-Rad, Hercules, CA, USA) was used to evaluate protein
concentrations. Samples of loading buffer, water, and 40 μg
of proteins were boiled at 95◦C for 5 min, then loaded on
8, 10, or 15% SDS-PAGE and transferred onto nitrocellu-
lose membranes. Afterward, membranes were blocked in 5%
BSA/TBS-Tween 0.1% for 1 h at room temperature and incu-
bated overnight at 4◦C with the primary antibodies diluted in 1%
BSA/TBS-Tween 0.1%. Antibodies were raised against phospho-
rylated mTOR at serine 2448 (Cell Signaling Technology, Beverly,
MA, USA, 1:1000), total mTOR (Cell signaling, 1:1000), which
recognized at the same time mTORC1 and mTORC2, phos-
phorylated P70S6K at threonine 389 (Cell signaling, 1:1000),
total P70S6K (Cell signaling, 1:1000), phosphorylated 4EBP1
at threonine 37 and 46 (Cell signaling, 1:1000), total 4EBP1
(Cell signaling, 1:1000) and GAPDH (Abcam, Cambridge, MA,
USA 1:20000). Membranes were washed and incubated with
corresponding anti-mouse or anti-rabbit secondary horseradish
peroxidase antibodies (Cell signaling, 1:5000) diluted in 1%
BSA/TBS-Tween 0.1% for 1 h at room temperature. To visualize
protein bands, chemiluminescence reactions were used (Super-
Signal West Femto chemiluminescence kit, Pierce Chemical Co,
Rockford, IL, USA). Quantiﬁcation was performed using the
Visonwork LS software (UVP bioimaging Upland, CA, USA)
and analyses of densitometry were expressed as relative optical
density.
STATISTICAL ANALYSIS
Data were analyzed with GraphPad Prism software (version 5.0,
Graph Pad Software, San Diego, CA, USA). Statistical analysis
was determined by unpaired Student’s t-test, one-way analysis of
variance (ANOVA) followed by theNewman–Keuls post hoc test or
two-way repeated-measures ANOVA followed by the Bonferroni
post hoc test. Data are shown as the mean ± S.E.M and statistical
signiﬁcance was set at P < 0.05.
RESULTS
ROTAROD LEARNING INDUCED mTOR ACTIVATION
As we previously published, the rotarod task illustrates the typical
phases of motor skill learning (Bureau et al., 2010). At the ﬁrst
day of training, mice enhanced rapidly their performance over
each trial corresponding to the early phase of learning. At the
second day, mice still improved their scores but to a much lower
extent, ﬁnally reaching a plateau on the third rotarod training
day. The second and third days of rotarod training illustrates the
consolidation phase of learning (Figure 2A).
In order to determine whether mTOR was activated during
rotarod training, levels of totalmTORaswell as levels of phospory-
lated mTOR at serine 2448 were assessed at days 1, 2, and 3
in the striatum, hippocampus, anterior cortex, and cerebellum.
One-way ANOVA followed by the Newman–Keuls post hoc test
was performed. At the ﬁrst day of rotarod training, levels of
phosphorylated mTOR were signiﬁcantly increased in the stria-
tum (F(3,15) = 6.17, P < 0.01) and hippocampus (F(3,15) = 4.29,
P < 0.05), but were equal to those of untrained mice at the second
and third days of training (Figures 2B,C). Levels of phospho-
rylated mTOR in the anterior cortex (F(3,11) = 0.84, P = 0.51)
and cerebellum (F(3,15) = 0.17, P = 0.91) of trained mice were
not signiﬁcantly different to the untrained mice at any training
day (Figures 2D,E). In all brain structures studied, levels of total
mTOR were unaffected by rotarod training (Figures 2B–E).
EFFECT OF SYSTEMIC AND INTRASTRIATAL INHIBITION OF mTOR ON
ROTAROD LEARNING
To investigate whether mTOR activity is involved in the learn-
ing of a complex motor task, the mTOR inhibitor rapamycin was
systemically injected in mice before every single rotarod training.
It is noteworthy that it was previously believed that a rapamycin
treatment could discriminate mTORC1 and mTORC2 (mTORC2
was considered rapamycin-resistant), but recent studies recog-
nized that rapamycin inhibited both complexes (Lamming et al.,
2012). On the ﬁrst training day, we observed a rapid improve-
ment of performances in both rapamycin-treated and control
mice. However, on the second and third day, the performances of
rapamycin-treated mice were signiﬁcantly lower than control mice
(Figure 3A). Statistical analysis of the two ﬁrst and two last trials
of each training session were achieved using a two-way repeated
measures ANOVA followed by the Bonferroni post hoc test. Analy-
sis of the ﬁrst trials displayed a signiﬁcant difference in treatments
(F(1,34) = 7.54,P < 0.05), an effect of trainingdays (F(2,34) = 57.95,
P < 0.001) and an interaction between treatments and training
days (F(2,34) = 4.23, P < 0.05; Figure 3A). Analysis of the last
trials indicated a signiﬁcant effect of treatment (F(1,34) = 6.96,
P < 0.05), training days (F(2,34) = 21.63, P < 0.001) as well as an
interaction between treatments and training days (F(2,34) = 3.53,
P < 0.05; Figure 3A).
We next investigated the effect of mTOR inhibition directly
in the dorsal striatum of mice during the rotarod learning. We
observed that performances of rapamycin-treated and control
mice were similar to those obtained with the systemic approach
(Figure 3B). Statistical analysis of the two ﬁrst trials revealed a sig-
niﬁcant difference in treatments (F(1,18) = 12.24, P < 0.01) and an
effect of training days (F(2,18) = 42.31, P < 0.001), but no interac-
tion between the treatments and the training days (F(2,18) = 0.50,
P > 0.05; Figure 3B). Analysis of the two last trials indicated a sig-
niﬁcant effect of treatment (F(1,18) = 21.07,P < 0.01) and training
days (F(2,18) = 19.27, P < 0.001), although no interaction between
the treatments and the training days was observed (F(2,18) = 3.45,
P > 0.05; Figure 3B).
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FIGURE 2 | Levels of phosphorylated mTOR is modulated by rotarod
training in specific brain regions. (A) Latency to fall on the accelerating
rotarod for each trial at days 1, 2, and 3. Levels of total mTOR and
phosphorylated mTOR were evaluated by western blot in the (B) striatum,
(C) hippocampus, (D) anterior cortex, and (E) cerebellum of trained mice at
days 1, 2, and 3. The data, expressed relative to levels of total mTOR,
represent the mean of relative optical density of phosphorylated mTOR
(expressed as a percentage of control values) ± S.E.M, n = 3 or 4;
triplicate experiments for each mouse/group. **P < 0.01 and *P < 0.05 vs.
respective untrained group.
To investigate the effect of systemic rapamycin injections on
motor activity endurance, mice were trained on the rotarod dur-
ing four days, including 10 assays per day. At the fourth day,
mice were treated with a systemic injection of either vehicle or
rapamycin. No difference was observed in rotarod performances
between rapamycin and vehicle-treated mice. Statistical analy-
sis, using a two-way repeated measures ANOVA followed by the
Bonferroni post hoc test, revealed no signiﬁcant difference in treat-
ments (F(1,15) = 0.03,P > 0.05), a signiﬁcant effect in training days
(F(3,15) = 23.57,P < 0.001) andno interaction between treatments
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FIGURE 3 | Systemic and intrastriatal inhibitions of mTOR by rapamycin
impaired motor learning. (A)Time spent by vehicle (DMSO) and
intraperitoneal (IP) rapamycin-treated mice on the accelerating rotarod for
each trial at days 1, 2, and 3. Rotarod learning was analyzed by pooling
together the two ﬁrst or the two last trials/training day of both groups. Values
represent the average mean latency to fall expressed in seconds ± S.E.M,
n = 8 vehicle-treated mice and n = 12 rapamycin-treated mice. **P < 0.01
and *P < 0.05 vs. respective vehicle-treated group. (B)Time spent by vehicle
(DMSO) and intrastriatal (IS) rapamycin-treated mice on the accelerating
rotarod for each trial at days 1, 2, and 3. Rotarod learning was analyzed by
pooling together the two ﬁrst or the two last trials/training day of both groups.
Values represent the average mean latency to fall expressed in
seconds ± S.E.M, n = 7 vehicle-treated mice and n = 4 rapamycin-treated
mice. ***P < 0.001 and *P < 0.05 vs. respective vehicle-treated group.
and training days (F(3,15) = 0.22, P > 0.05; Figure 4A). To verify
whether the systemic or intrastriatal rapamycin treatments inter-
fered with motor abilities, the pole test was performed. A similar
amount of time was required to perform the task in systemic
(Unpaired t-test, P = 0.38) and instrastriatal (Unpaired t-test,
P = 0.78) rapamycin-treated mice compared to their respective
control (Figure 4B).
RAPAMYCIN TREATMENTS REDUCED THE LEVELS OF
PHOSPHORYLATED P70S6K AND 4EBP1 IN THE STRIATUM
The levels of P70S6K and 4EBP1, two mTORC1 downstream
substrates, as well as the levels of their phosphorylated form
were evaluated following rapamycin treatments. We observed
that the levels of phosphorylated P70S6K at Thr389 (Unpaired
t-test, P < 0.01) and 4EBP1 at Thr37/46 (Unpaired t-test,
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FIGURE 4 | Motor abilities are not affected in mice after mTOR
inhibitions. (A) Mice were trained on the accelerating rotarod during
4 days. At day 4, mice were systemically injected with either vehicle
(DMSO) or rapamycin. Data represent the average mean latency to
fall expressed in seconds from 10 assays per training day ± S.E.M,
n = 3–4 mice/group. (B) Motor abilities in systemic and intrastriatal
rapamycin-treated mice were assessed by the pole test and
compared to the vehicle (DMSO) treated mice. Data represent the
time required to perform the task in seconds ± S.E.M, n = 3–12
mice/groups.
P < 0.001) were strongly reduced after the intraperitoneal
rapamycin treatments (Figures 5A,B). Likewise, levels of phos-
phorylated P70S6K (Unpaired t-test, P < 0.001) and 4EBP1
(Unpaired t-test, P < 0.001) were reduced after the intrastri-
atal rapamycin treatments (Figures 5C,D). Interestingly, both
treatments did not affect the levels of total P70S6K and 4EBP1
(Figures 5A–D).
INTRASTRIATAL INFUSION OF mTOR siRNA ALTERED ROTAROD
LEARNING AND DECREASED THE PHOSPHORYLATION LEVELS OF
STRIATAL mTORC1 DOWNSTREAM SUBSTRATES
In order to further conﬁrm the implication of mTOR in motor
skill learning, we infused directly into the dorsal striatum a spe-
ciﬁc mTOR siRNA during 14 consecutive days. On the 12th, 13th,
and 14th days, we assessed the latency to fall on the accelerating
rotarod. During the ﬁrst day of training, there were no difference
in the performances of siRNA and vehicle-treated mice. However,
performances of the siRNA-treated mice were lower on the sec-
ond and third day, when compared to their respective controls
(Figure 6A). Statistical analyses of the two ﬁrst and the two last
trials of every rotarod training day were performed using a two-
way repeated measures ANOVA followed by the Bonferroni post
hoc test. The analysis of the two ﬁrst trials revealed no signiﬁcant
difference in treatments (F(1,10) = 1.89, P > 0.05), a signiﬁ-
cant effect in training days (F(2,10) = 23.08, P < 0.001) and no
interaction between treatments and training days (F(2,10) = 1.26,
P > 0.05; Figure 6A). However, statistical analysis of the two
last rotarod trials displayed a signiﬁcant effect of siRNA treatment
(F(1,10) = 24.41, P < 0.01) and training days (F(2,10) = 12.37,
P < 0.01), although no interaction between siRNA treatment and
training days was observed (F(2,10) = 1.7, P > 0.05; Figure 6A).
The siRNA-treated mice were also tested with the pole test and no
signiﬁcant difference between these mice and the vehicle-treated
mice was observed (Unpaired t-test, P = 1.00; Figure 6B).
The effect of siRNA infusion on the levels of striatal mTOR,
P70S6K and 4EBP1 were veriﬁed. We observed that levels of total
mTOR were decreased by ∼25% in the siRNA-treated mice when
compared to vehicle-treated mice (Unpaired t-test, P < 0.01;
Figure 7A). This result conﬁrmed that our experiment design
was sound considering that previous work using siRNA injections
in the striatum of a living mouse revealed a reduction of the tar-
geted proteins within the range of 40% (Thakker et al., 2004).
Interestingly, levels of phosphorylated P70S6K (Unpaired t-test,
P < 0.01) and 4EBP1 (Unpaired t-test, P < 0.05) were also signiﬁ-
cantly decreased compared to vehicle-treatedmice (Figures 7B,C).
No difference in levels of total P70S6K and 4EBP1 was observed
in both groups of mice (Figures 7A–C).
DISCUSSION
At the behavioral level, our study demonstrates that inhibition of
mTOR activity impaired signiﬁcantly motor learning. We believe
these effects on motor behavior are reminiscent of a learning
deﬁcit as our ﬁndings argue against a role of mTOR in motor
capacity. The ﬁrst evidence is the fact that a reduced mTOR activ-
ity does not affect the performances of mice at the pole test. In
addition, peripheral rapamycin injections in mice that have fully
learned the accelerating rotarod task have no effect. This partic-
ular ﬁnding is supported by a previous study demonstrating that
systemic administrations of rapamycin do not affect mice per-
formances when they are pre-trained on the rotarod (Deli et al.,
2012). Moreover, the fact that both systemic and intrastriatal
treatments lead to similar results suggests that possible effects
of mTOR inhibition on peripheral functions such as muscles
strength are unlikely. It is noteworthy that motor skill learn-
ing is assumed to be the major component responsible for the
improvement in performance observed during rotarod training.
The distinctive characteristic of the rotarod task is its indepen-
dence to reward, spatial and instrumental features (Buitrago et al.,
2004; Luft and Buitrago, 2005). Falling off the rod may repre-
sent a weak aversive stimulus. However, the distance to fall is
small (40 cm) and we avoid additional aversive stimuli such as
electric shocks. Taken together, it becomes evident that mTOR
activities do not alter motor capacity but rather govern motor skill
learning.
Our data demonstrate a differential involvement of brain struc-
tures during the acquisition of the rotarod task. In the striatum
and hippocampus, mTOR activity is enhanced during the ﬁrst day
of rotarod training whereas no effect is noticed in the anterior
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FIGURE 5 | Systemic and intrastriatal rapamycin treatments decreased
the phosphorylation levels of striatal mTORC1 downstream substrates.
Levels of total and phosphorylated (A) P70S6K and (B) 4EBP1 were
evaluated by western blot after systemic rapamycin treatments. The data,
expressed to relative total P70S6K or 4EBP1 levels, represent the mean of
relative optical density of phosphorylated P70S6K or 4EBP1 (expressed as a
percentage of control values) ± S.E.M, n = 8–12 vehicle (DMSO) and
rapamycin-treated mice; triplicate experiments for each mouse/group.
***P < 0.001 and **P < 0.01 vs. vehicle-treated group. Levels of total and
phosphorylated (C) P70S6K and (D) 4EBP1 were also evaluated following
instrastriatal rapamycin treatments. The data, expressed to relative total
P70S6K or 4EBP1 levels, represent the mean of relative optical density of
phosphorylated P70S6K or 4EBP1 (expressed as a percentage of control
values) ± S.E.M, n = 3–4 vehicle (DMSO) and rapamycin-treated mice;
triplicate experiments for each mouse/group. ***P < 0.001 vs.
vehicle-treated group.
cortex or the cerebellum. This is somewhat intriguing because
these two last structures are also known to be engaged dur-
ing the learning of a complex motor skill (Doyon and Benali,
2005; Bureau et al., 2010). We, and other groups, have previously
documented that the participation of speciﬁc molecular path-
ways in motor skilled learning are differentially regulated over
time and by the numbers of task repetitions (Yin et al., 2009;
Bureau et al., 2010; D’Amours et al., 2011; Lemay-Clermont et al.,
2011; Shiﬂett and Balleine, 2011). For instance, levels of phos-
phorylated ERK 1/2 were selectively induced in parallel with an
upregulation of c-Fos in the cerebellum, motor cortex, cingu-
late cortex and dorsal striatum during the consolidation phase
(Bureau et al., 2010). It is conceivable that a transitory surge of
mTOR activity occurs in the cortex and cerebellum, which was
returned to normal levels at the time we sacriﬁced the animal.
Our data in the hippocampus are interesting because previous
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FIGURE 6 | mTOR siRNA infusion impaired rotarod learning. (A)Time
spent by vehicle (distillated/deionized water DNase/RNase free) and
siRNA-treated mice on the accelerating rotarod for each trial at days 1, 2, and
3. Rotarod learning was analyzed by pooling together the two ﬁrst or the two
last trials/training day of both groups. Data represent the average mean
latency to fall expressed in seconds ± S.E.M, n = 3–4 vehicle-treated and
siRNA-treated mice. **P < 0.01 and *P < 0.05 vs. respective vehicle-treated
group. (B) Motor abilities of mTOR siRNA-treated mice were also assessed by
the pole test and compared to their respective controls. Data represent the
time required to perform the task in second ± S.E.M, n = 3–4 mice/groups.
studies have demonstrated that it is not considerably engaged dur-
ing the rotarod training, despite its recognized role in long-term
memory and spatial learning (Bureau et al., 2010). It would be
interesting to investigate whether this increase of mTOR levels
after the ﬁrst session of rotarod is due to motor skill learning
or to hippocampal dependent behaviors such as spatial learn-
ing or object recognition. Further analysis is ultimately needed
to conclude on the role of mTOR in the anterior cortex, the cere-
bellum or the hippocampus. Nonetheless, using rapamycin and
siRNA treatments, we demonstrate that mTOR of the dorsal stria-
tum is mandatory to motor skill learning. Previous studies have
demonstrated the importance of the striatum structure in rotarod
training. For instance, rotarod training is completely abolished
in the striatum speciﬁc NMDAR1 knockout mice (Dang et al.,
2006). Interestingly, in our experiments, rapamycin and siRNA
treatments do not completely prevent the improvement of per-
formances during rotarod trainings. As no previous study has
directly assessed the role of mTOR in motor behavior, it is dif-
ﬁcult to compare our data with the literature. It has been shown
that mice with genetic deletion of the mTOR downstream target
4EBP2 display low performances at every session of the acceler-
ating rotarod trainings (Banko et al., 2007). However, impaired
motor coordination and balance were suspected in this study,
but no other tests of motor abilities were performed to dis-
criminate motor execution from motor learning. Many causes
could account for an incomplete effect of mTOR inhibitions.
Rapamycin and siRNA treatments seem to provide only a par-
tial inhibitory effect on striatal mTOR activity, as measured by
the protein levels of the mTOR targets P70S6K and 4EBP1. Adap-
tive mechanisms may perhaps compensate and counterbalance
the reduction in mTOR activity. This is a very interesting idea
that merit to be investigated in future. At some point, we believe
it will be possible to establish a heuristic model of the mTOR
activation at different sites of the brain and understand how
these pathways are elaborate in, or the result of, long-term motor
learning.
The present study demonstrates that striatal mTOR activity
has no inﬂuence in the early phase of learning but interferes
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FIGURE 7 | mTOR siRNA infusion inhibited striatal mTOR expression and
decreased the levels of phosphorylated P70S6K and 4EBP1. (A) Levels of
total striatal mTOR were evaluated by western blot after the infusion of
vehicle (distillated/deionized water DNase/RNase free) or mTOR siRNA. The
data, expressed relative to GAPDH, represent the mean of relative optical
density of total mTOR (expressed as a percentage of control values) ± S.E.M,
n = 3–4; triplicate experiments for each mouse/group. **P < 0.01 vs.
vehicle-treated group. Levels of total and phosphorylated (B) P70S6K and
(C) 4EBP1 were also evaluated. The data, expressed to relative levels of total
P70S6K or 4EBP1, represent the mean of relative optical density of
phosphorylated P70S6K or 4EBP1 (expressed as a percentage of control
values) ± S.E.M, n = 3–4 vehicle-treated and siRNA-treated mice; triplicate
experiments for each mouse/group. **P < 0.01 and *P < 0.05 vs.
vehicle-treated group.
with the later phases during the accelerating rotarod training,
which are known to be associated with consolidation processes
(Luft and Buitrago, 2005). Notably, mTOR inhibitions have been
shown to alter memory consolidation and the long-term memory
processes of other types of learning task such as non-reinforced
retrieval of inhibitory avoidance conditioning (a fear-motivated
memory task), in discrimination of complex auditory stimuli
as well as in a fear conditioning task (Schicknick et al., 2008;
Sui et al., 2008; Jobim et al., 2011a,b). A role for mTOR in
general memory processes is predictable based on the numer-
ous published studies on this topic (Jernigan et al., 2011; Talos
et al., 2012; Chandran et al., 2013), but its implication in the
encoding processes associated with long-term motor memory
is novel. During the learning of a complex motor task, short-
term improvements occur over repeated running trials within
the ﬁrst session (intrasession). Long-term improvements (inter-
session) develop over two to three sessions with rest periods
between each session. This later type of memory stabilization
involves neuronal processing after the training that transfers the
memory from an unsteady state to a more stable state (Yin
et al., 2009). Our data demonstrate that phosphorylation levels
of mTOR are enhanced at the end of the ﬁrst session, whereas
they are not affected on the following sessions. This indicates
that mTOR protein activation is necessary to initiate the molec-
ular sequence leading to memory stabilization during rotarod
training. Further experiments would be necessary to investigate
how mTOR activation could inﬂuence molecular mechanisms of
motor memory from an unsteady state to a more stable state.
Our ﬁndings do propose, however, that the activity of two down-
stream molecular targets of mTORC1, P70S6K, and 4EBP1, are
clearly involved. Such as demonstrated previously in vitro and
in vivo (Sarbassov et al., 2005; Wang and Proud, 2006; Hoeffer
and Klann, 2009; Urbanska et al., 2012), we observed a reduc-
tion in the levels of phosphorylated P70S6K and phosphorylated
4EBP1 following systemic or intrastriatal injections of rapamycin
as well as intrastriatal genetic knockdown of mTOR. Therefore,
depressing downstream molecular targets of mTORC1 is associ-
ated with impaired memory consolidation during the learning of
a complex motor skill.
By using pharmacological and siRNA tools, in the dorsal
striatum, we have demonstrated that mTOR activation play a
signiﬁcant role in motor learning processes. In particular, we
established that mTORC1 activation via the phosphorylation
of P70S6K and 4EBP1 is one important molecular pathway
implicated in the consolidation of the learning, but not the
execution capacity of the accelerating rotarod skill. Understand-
ing the relationship between molecular processes and motor
adaptive behavior is an important but daunting goal in this
research ﬁeld. We believe our study makes one step further
toward a better understanding of proteins interaction, orga-
nization and function and this will lead to a global view of
the role of synapses in the control and learning of motor
behaviors.
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